U.K.-based digital manufacturing service provider, Fluxaxis, has 3D printed two life-size master figures that were integral to a recent “Make Blood Cancer Visible” campaign for pharmaceutical company, Janssen. The figures were used by Fluxaxis’ customer, Windsor Workshop, to create molds for a series of ten life-size human bodies designed to convey the invisible nature of blood cancer.
Fluxaxis produced the models on its Massivit 1800 3D Printer in less than eight hours each. This drastically reduced both the time and costs involved in creating the display compared to traditional production methods.
Designed to give blood cancer well-deserved priority and recognition within the UK, real-life recordings of people with the disease were emitted from the human figures to enhance the sensory impact. The campaign travelled to key locations across London, Cardiff, Manchester, and Edinburgh and received widespread pick-up across social media platforms.
Watch the making-of video and its stunning execution here.
About Massivit 3D
Massivit 3D Printing Technologies Ltd. (www.massivit3d.com) is a leading provider of large format 3D printing solutions for visual communication. The company’s solutions enable the creation of super-size advertising, promotional and other marketing-oriented 3D printed sign and display projects for a growing range of sectors—including retail, events and exhibitions, entertainment, and architecture. Massivit 3D’s proprietary Gel Dispensing Printing (GDP) technology leverages the company’s unique, instantly-curing printing gel, Dimengel, to quickly and cost-effectively produce lightweight, hollow 3D printed models up to six feet high.
Founded in 2013 by a team of digital printing pioneers, Massivit 3D is headquartered in Lod, Israel, and serves customers worldwide with end-to-end services and through a well-distributed network of global resellers.